Purchases and Sales Made in Q4 2022 in Pliant Therapeutics, Inc. (PLRX)
This table provides information about the institutional ownership of Pliant Therapeutics, Inc. (PLRX) during Q4 2022. The information is specifically focused on institutions that hold shares of PLIANT THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 21, 2024
Q4 2022
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-11.1K- 95.73% |
$188K - $282K
|
495
$6.1K
|
|
|
Feb 14, 2023
Q4 2022
|
Unc Management Company, Inc.
Chapel Hill, NC |
SELL
|
- |
-19K- 37.91% |
$323K - $484K
|
31.2K
$384K
|
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-22K- 59.54% |
$374K - $560K
|
15K
$184K
|
|
|
Feb 14, 2023
Q4 2022
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-26K- 8.71% |
$442K - $661K
|
272K
$3.36M
|
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-26.1K- 2.12% |
$444K - $664K
|
1.21M
$14.9M
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-30.6K- 12.32% |
$520K - $777K
|
217K
$2.68M
|
|
|
Feb 13, 2023
Q4 2022
|
Bessemer Group Inc
Woodbridge, NJ |
SELL
|
- |
-34.4K- 5.83% |
$584K - $874K
|
555K
$6.84M
|
|
|
Feb 14, 2023
Q4 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-39.9K- 38.88% |
$678K - $1.01M
|
62.7K
$773K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-49.1K- 69.72% |
$834K - $1.25M
|
21.3K
$262K
|
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-73.5K- 77.94% |
$1.25M - $1.87M
|
20.8K
$256K
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-99.7K- 46.66% |
$1.7M - $2.54M
|
114K
$1.4M
|
|
|
Feb 14, 2023
Q4 2022
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-115K- 53.49% |
$1.96M - $2.92M
|
100K
$1.23M
|
|
|
Nov 08, 2023
Q4 2022
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-157K- 53.27% |
$2.66M - $3.98M
|
137K
$1.69M
|
|
|
Feb 14, 2023
Q4 2022
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-157K- 53.27% |
$2.66M - $3.98M
|
137K
$1.69M
|
|
|
Feb 13, 2023
Q4 2022
|
Chi Advisors LLC
New York, NY |
SELL
|
- |
-240K- 7.03% |
$4.08M - $6.1M
|
3.17M
$39.1M
|
|
|
Feb 14, 2023
Q4 2022
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-630K- 13.97% |
$10.7M - $16M
|
3.88M
$47.8M
|
|
|
Feb 14, 2023
Q4 2022
|
Trv Gp Iii, LLC
Boston, MA |
SELL
|
- |
-2M- 52.09% |
$34M - $50.9M
|
1.84M
$22.7M
|